Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - SMARCA-BD ligand 1 for Protac dihydrochloride

SMARCA-BD ligand 1 for Protac dihydrochloride

CAS No. 2369053-68-7

SMARCA-BD ligand 1 for Protac dihydrochloride( —— )

Catalog No. M33234 CAS No. 2369053-68-7

SMARCA-BD ligand 1 for Protac dihydrochloride binds to the BAF ATPase subunit SMARCA2 and is used for degrading SMARCA2 based on PROTAC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 84 In Stock
10MG 136 In Stock
25MG 226 In Stock
50MG 317 In Stock
100MG 434 In Stock
200MG 602 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SMARCA-BD ligand 1 for Protac dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    SMARCA-BD ligand 1 for Protac dihydrochloride binds to the BAF ATPase subunit SMARCA2 and is used for degrading SMARCA2 based on PROTAC.
  • Description
    SMARCA-BD ligand 1 for Protac dihydrochloride is a compound that binds to the BAF ATPase subunits SMARCA2, and used for degrading SMARCA2, based on PROTAC.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Epigenetic Reader Domain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2369053-68-7
  • Formula Weight
    344.24
  • Molecular Formula
    C14H19Cl2N5O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 2.7 mg/mL (7.84 mM; Ultrasonic (<60°C)
  • SMILES
    Cl.Cl.Nc1nnc(cc1N1CCNCC1)-c1ccccc1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Farnaby W, et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat Chem Biol. 2019 Jul;15(7):672-680.?
molnova catalog
related products
  • Cyclogalegenol

    Astramembrangenin (Cycloastragenol) is a triterpenoid saponin compound and a hydrolysis product of the main active ingredient in Astragalus membranaceus.?Cycloastragenol (CAG) may have a novel therapeutic role in depression.

  • Y06137

    Y06137 is an effective and selective BET inhibitor with a Kd of 81 nM for BRD4(1) bromodomain. Y06137 can be used for research on the treatment of castration-resistant prostate cancer.

  • IRAK4-IN-1

    IRAK4-IN-1 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor with an IC50 of 7 nM.